Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Hims & Hers Health, Inc. (HIMS)

Barclays initiates coverage on Hims & Hers ($HIMS) with an Overweight rating and a $XX price target, citing new growth drivers and expansion into Europe and Canada. Recent social posts highlight potential price targets around $40-$48 and a bullish outlook on the stock's next move.

### About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. is a telehealth platform focused on health and wellness services.  
Hims & Hers Health, Inc. uses the ticker $HIMS for trading. Listed in the [Stocks](/list/stocks) category within the [Consumer Defensive](/list/stocks/consumer-defensive) sectors.

### Insights
- Hims & Hers Health, Inc. (HIMS) trading volume is up XXXXX% from the previous week.
- Hims & Hers Health, Inc. (HIMS) social dominance is up XXXXXX% from the previous week.
- Hims & Hers Health, Inc. Sentiment hit a 52-Week high of XX for the day

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:hims-hers/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/hims-hers/time-series/close.tsv)  
Despite recent EPS misses causing price declines, the stock shows potential for rebound due to new initiatives like the share repurchase program and positive social sentiment, with recent social posts suggesting a potential bottoming out and a 'buy the dip' sentiment among some investors.  

24-Hour: -XXXX%
7-Day: XXXX%
30-Day: -XXX%

1-Year High: $XXXXX on 2025-02-19  
1-Year Low: $XXXXX on 2025-01-01  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:hims-hers/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/hims-hers/time-series/alt_rank.tsv)  
Hims & Hers Health, Inc. (HIMS) is currently AltRank #130 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XX -XXX  
X Month: XX -XXX  
X Months: XX -XXX  
X Year: XX -XX  
1-Year High: XXXXX on 2025-08-12  
1-Year Low: X on 2025-03-09  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:hims-hers/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/hims-hers/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX -X  
X Month: XX -XX  
X Months: XX -X  
X Year: XX -X  
1-Year High: XX on 2025-03-24  
1-Year Low: X on 2024-12-11  
  
  
### Engagements: XXXXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:hims-hers/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/hims-hers/time-series/interactions.tsv)  
Current Value: XXXXXXX  
Daily Average: XXXXXXXXX  
X Week: XXXXXXXXX -XX%  
X Month: XXXXXXXXXX -XX%  
X Months: XXXXXXXXXXX +13%  
X Year: XXXXXXXXXXX +355%  
1-Year High: XXXXXXXXXX on 2025-06-23  
1-Year Low: XXXXXXX on 2025-01-27  

Engagements by network (24h):
Reddit: XX
TikTok: XXXXXX
X: XXXXXXX
YouTube: XXXXX

  
  
### Mentions: XXXXX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:hims-hers/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/hims-hers/time-series/posts_active.tsv)  
Current Value: XXXXX  
Daily Average: XXXXX  
X Week: XXXXX -XX%  
X Month: XXXXXX -XX%  
X Months: XXXXXXX +75%  
X Year: XXXXXXX +354%  
1-Year High: XXXXXX on 2025-06-25  
1-Year Low: XXX on 2025-01-28  

Mentions by network (24h):
Reddit: XX
TikTok: XXX
X: XXXXXX
YouTube: XXX

  
  
### Creators: XXX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:hims-hers/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/hims-hers/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Hims & Hers Health, Inc. (HIMS) in the last XX hours which is down XXXX% from XXX in the previous XX hours
Daily Average: XXXXX  
X Week: XXXXX -XX%  
X Month: XXXXX -XX%  
X Months: XXXXXX +126%  
X Year: XXXXXX +430%  
1-Year High: XXXXX on 2025-06-27  
1-Year Low: XXX on 2025-01-27  

The most influential creators that mention Hims & Hers Health, Inc. in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@himshouse](/creator/twitter/himshouse)             | X    | XXXXXX    | XX    | XXXXXX      |
| [@DeepIceValue](/creator/twitter/DeepIceValue)       | X    | XXXXXX    | X     | XXXXXX      |
| [@TheRayMyers](/creator/twitter/TheRayMyers)         | X    | XXXXXX    | XX    | XXXXXX      |
| [@EndicottInvests](/creator/twitter/EndicottInvests) | X    | XXXXXX    | X     | XXXXXX      |
| [@moninvestor](/creator/twitter/moninvestor)         | X    | XXXXXX    | XX    | XXXXXX      |
| [@MMatters22596](/creator/twitter/MMatters22596)     | X    | XXXXXX    | XX    | XXXXXX      |
| [@Han_Akamatsu](/creator/twitter/Han_Akamatsu)       | X    | XXXXXX    | XX    | XXXXXX      |
| [@TheValueTrade](/creator/twitter/TheValueTrade)     | X    | XXXXXX    | XX    | XXXXXX      |
| [@LEAPTRADER_](/creator/twitter/LEAPTRADER_)         | X    | XXXXXX    | X     | XXXXXX      |
| [@SteveUrkelDude](/creator/twitter/SteveUrkelDude)   | XX   | XXXXXX    | X     | XXXXXX      |

[View More](/list/creators/hims-hers/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:hims-hers/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/hims-hers/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -X%  
X Month: XX% -X%  
X Months: XX% +7%  
X Year: XX% +6%  
1-Year High: XX% on 2025-12-06  
1-Year Low: XX% on 2025-10-29  

Most Supportive Themes:
- Growth Potential in New Verticals: (40%) Hims & Hers is expanding into new areas like weight loss and men's health, which investors see as a significant growth opportunity.
- Market Position and Innovation: (35%) The company is recognized for its strong market standing and innovative approach to disrupting the healthcare industry.
- Bullish Chart Signals: (25%) Technical analysis of HIMS's stock charts suggests positive trends and potential for upward movement.
  
Most Critical Themes:
- Regulatory and Competitive Concerns: (100%) Concerns exist regarding potential regulatory hurdles and the competitive landscape from other telehealth providers and large pharmaceutical companies.
  
  
  
### Social Dominance: XXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:hims-hers/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/hims-hers/time-series/social_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: XXXXX%  
X Week: XXXXX% +0.553%  
X Month: XXXXX% +0.013%  
X Months: XXXXX% -XXXX%  
X Year: XXXXX% -XXXXX%  
1-Year High: XXXX% on 2025-06-25  
1-Year Low: XXXXX% on 2025-12-07  
  
  
### Market Dominance: XXXXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:hims-hers/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/hims-hers/time-series/market_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-02-19  
1-Year Low: XXXX% on 2025-12-10  
  
  
### Market Cap: $XXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:hims-hers/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/hims-hers/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXX +$4.60%  
X Month: $XXXXXXXXXXXXX -$6.60%  
X Months: $XXXXXXXXXXXXX -$30%  
X Year: $XXXXXXXXXXXXX +$29%  
1-Year High: $XXXXXXXXXXXXXX on 2025-02-19  
1-Year Low: $XXXXXXXXXXXXX on 2024-12-31  

### Top Hims & Hers Health, Inc. Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$HIMS $LLY $NVO Three months ago Diana Harshbarger (R-TN) and Buddy Carter (R-GA) introduced a bill designed to expand the authority of compounding pharmacies -- clearly very supportive of both 503A and 503B compounders. (Harshbarger and Carter are the only X pharmacists serving in the House of Representatives) The proposal received essentially X attention from mainstream or legacy media. Notable because if enacted the bill would likely be bullish for $HIMS: it would reinforce compounders' ability to operate during drug shortages and mandate annual updates to the FDA's bulk drug substances"  
[X Link](https://x.com/himshouse/status/1998822054494150656) [@himshouse](/creator/x/himshouse) 2025-12-10T18:28Z 35.3K followers, 8622 engagements


"Long-term buying opportunities worth paying attention to: $HIMS $OSCR $BULL $PATH $SOUN $NVO $UNH $GLXY $SQ $PYPL $AFRM $SOFI $MQ $FOUR $UPST $GLBE $NU $PAGS $STNE $MELI $ALLY $EXLS $PAY $EVTC $GPN $FISV $FIS $MA $V $NIO $LI $XPEV $RIVN $LCID $CHPT $BLNK $ENPH"  
[X Link](https://x.com/SMALLCAPSAXIS/status/1998821460891025572) [@SMALLCAPSAXIS](/creator/x/SMALLCAPSAXIS) 2025-12-10T18:25Z XXX followers, 1000 engagements


"🚨 2025 LOBBYING SPEND - $HIMS vs. BIG PHARMA $LLY: $8.8m $NVO: $5.7m $HIMS: $860k $HIMS was at $X through 2022. Then spent $20k in 2023. $310k in 2024. And now is at $860k as of Q3 2025. Clearly more of a focus for $HIMS but still less than XX% of what $LLY has spent this year. h/t @edwrdmoreno"  
[X Link](https://x.com/himshouse/status/1998815383801713096) [@himshouse](/creator/x/himshouse) 2025-12-10T18:01Z 35.3K followers, 6342 engagements


"$HIMS If this ever squeezes its going to $XXX. The Market has ignored all of this.👇 Canada expansion UK launch Labs at-home launch Low testosterone treatment launch New $250M buyback YourBio acquisition $UNH $LLY $NVO $OSCR $SPY $XLV $OPEN $GME $APLD $PLTR"  
[X Link](https://x.com/bullrunalpha/status/1998812305291874770) [@bullrunalpha](/creator/x/bullrunalpha) 2025-12-10T17:49Z XXX followers, 2550 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Hims & Hers Health, Inc. (HIMS)

Barclays initiates coverage on Hims & Hers ($HIMS) with an Overweight rating and a $XX price target, citing new growth drivers and expansion into Europe and Canada. Recent social posts highlight potential price targets around $40-$48 and a bullish outlook on the stock's next move.

About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. is a telehealth platform focused on health and wellness services.
Hims & Hers Health, Inc. uses the ticker $HIMS for trading. Listed in the Stocks category within the Consumer Defensive sectors.

Insights

  • Hims & Hers Health, Inc. (HIMS) trading volume is up XXXXX% from the previous week.
  • Hims & Hers Health, Inc. (HIMS) social dominance is up XXXXXX% from the previous week.
  • Hims & Hers Health, Inc. Sentiment hit a 52-Week high of XX for the day

Price: $XXXXX

Price Line Chart
Price 24-Hour Time-Series Raw Data
Despite recent EPS misses causing price declines, the stock shows potential for rebound due to new initiatives like the share repurchase program and positive social sentiment, with recent social posts suggesting a potential bottoming out and a 'buy the dip' sentiment among some investors.

24-Hour: -XXXX% 7-Day: XXXX% 30-Day: -XXX%

1-Year High: $XXXXX on 2025-02-19
1-Year Low: $XXXXX on 2025-01-01

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Hims & Hers Health, Inc. (HIMS) is currently AltRank #130 based on combined combined social and market metrics Daily Average: XXX
X Week: XX -XXX
X Month: XX -XXX
X Months: XX -XXX
X Year: XX -XX
1-Year High: XXXXX on 2025-08-12
1-Year Low: X on 2025-03-09

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -X
X Month: XX -XX
X Months: XX -X
X Year: XX -X
1-Year High: XX on 2025-03-24
1-Year Low: X on 2024-12-11

Engagements: XXXXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXXX
Daily Average: XXXXXXXXX
X Week: XXXXXXXXX -XX%
X Month: XXXXXXXXXX -XX%
X Months: XXXXXXXXXXX +13%
X Year: XXXXXXXXXXX +355%
1-Year High: XXXXXXXXXX on 2025-06-23
1-Year Low: XXXXXXX on 2025-01-27

Engagements by network (24h): Reddit: XX TikTok: XXXXXX X: XXXXXXX YouTube: XXXXX

Mentions: XXXXX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXXX +75%
X Year: XXXXXXX +354%
1-Year High: XXXXXX on 2025-06-25
1-Year Low: XXX on 2025-01-28

Mentions by network (24h): Reddit: XX TikTok: XXX X: XXXXXX YouTube: XXX

Creators: XXX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Hims & Hers Health, Inc. (HIMS) in the last XX hours which is down XXXX% from XXX in the previous XX hours Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXX -XX%
X Months: XXXXXX +126%
X Year: XXXXXX +430%
1-Year High: XXXXX on 2025-06-27
1-Year Low: XXX on 2025-01-27

The most influential creators that mention Hims & Hers Health, Inc. in the last XX hours

Creator Rank Followers Posts Engagements
@himshouse X XXXXXX XX XXXXXX
@DeepIceValue X XXXXXX X XXXXXX
@TheRayMyers X XXXXXX XX XXXXXX
@EndicottInvests X XXXXXX X XXXXXX
@moninvestor X XXXXXX XX XXXXXX
@MMatters22596 X XXXXXX XX XXXXXX
@Han_Akamatsu X XXXXXX XX XXXXXX
@TheValueTrade X XXXXXX XX XXXXXX
@LEAPTRADER_ X XXXXXX X XXXXXX
@SteveUrkelDude XX XXXXXX X XXXXXX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -X%
X Months: XX% +7%
X Year: XX% +6%
1-Year High: XX% on 2025-12-06
1-Year Low: XX% on 2025-10-29

Most Supportive Themes:

  • Growth Potential in New Verticals: (40%) Hims & Hers is expanding into new areas like weight loss and men's health, which investors see as a significant growth opportunity.
  • Market Position and Innovation: (35%) The company is recognized for its strong market standing and innovative approach to disrupting the healthcare industry.
  • Bullish Chart Signals: (25%) Technical analysis of HIMS's stock charts suggests positive trends and potential for upward movement.

Most Critical Themes:

  • Regulatory and Competitive Concerns: (100%) Concerns exist regarding potential regulatory hurdles and the competitive landscape from other telehealth providers and large pharmaceutical companies.

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.553%
X Month: XXXXX% +0.013%
X Months: XXXXX% -XXXX%
X Year: XXXXX% -XXXXX%
1-Year High: XXXX% on 2025-06-25
1-Year Low: XXXXX% on 2025-12-07

Market Dominance: XXXXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-02-19
1-Year Low: XXXX% on 2025-12-10

Market Cap: $XXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$4.60%
X Month: $XXXXXXXXXXXXX -$6.60%
X Months: $XXXXXXXXXXXXX -$30%
X Year: $XXXXXXXXXXXXX +$29%
1-Year High: $XXXXXXXXXXXXXX on 2025-02-19
1-Year Low: $XXXXXXXXXXXXX on 2024-12-31

Top Hims & Hers Health, Inc. Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$HIMS $LLY $NVO Three months ago Diana Harshbarger (R-TN) and Buddy Carter (R-GA) introduced a bill designed to expand the authority of compounding pharmacies -- clearly very supportive of both 503A and 503B compounders. (Harshbarger and Carter are the only X pharmacists serving in the House of Representatives) The proposal received essentially X attention from mainstream or legacy media. Notable because if enacted the bill would likely be bullish for $HIMS: it would reinforce compounders' ability to operate during drug shortages and mandate annual updates to the FDA's bulk drug substances"
X Link @himshouse 2025-12-10T18:28Z 35.3K followers, 8622 engagements

"Long-term buying opportunities worth paying attention to: $HIMS $OSCR $BULL $PATH $SOUN $NVO $UNH $GLXY $SQ $PYPL $AFRM $SOFI $MQ $FOUR $UPST $GLBE $NU $PAGS $STNE $MELI $ALLY $EXLS $PAY $EVTC $GPN $FISV $FIS $MA $V $NIO $LI $XPEV $RIVN $LCID $CHPT $BLNK $ENPH"
X Link @SMALLCAPSAXIS 2025-12-10T18:25Z XXX followers, 1000 engagements

"🚨 2025 LOBBYING SPEND - $HIMS vs. BIG PHARMA $LLY: $8.8m $NVO: $5.7m $HIMS: $860k $HIMS was at $X through 2022. Then spent $20k in 2023. $310k in 2024. And now is at $860k as of Q3 2025. Clearly more of a focus for $HIMS but still less than XX% of what $LLY has spent this year. h/t @edwrdmoreno"
X Link @himshouse 2025-12-10T18:01Z 35.3K followers, 6342 engagements

"$HIMS If this ever squeezes its going to $XXX. The Market has ignored all of this.👇 Canada expansion UK launch Labs at-home launch Low testosterone treatment launch New $250M buyback YourBio acquisition $UNH $LLY $NVO $OSCR $SPY $XLV $OPEN $GME $APLD $PLTR"
X Link @bullrunalpha 2025-12-10T17:49Z XXX followers, 2550 engagements

Hims & Hers Health, Inc. (HIMS)
/topic/hims-hers